Chemotherapy and intensity modulated radiation therapy (IMRT) for stage III non-small cell lung cancer (NSCLC)

被引:0
|
作者
Laser, B. [1 ]
Yorke, E. D. [1 ]
Jackson, A. [1 ]
Sura, S. [1 ]
Rosenzweig, K. E. [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
关键词
D O I
10.1016/j.ijrobp.2008.06.1350
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S429 / S429
页数:1
相关论文
共 50 条
  • [21] RADIOTHERAPY FOR STAGE III NON-SMALL CELL LUNG CANCER (NSCLC)
    De Ruysscher, D.
    LUNG CANCER, 2009, 64 : S21 - S21
  • [22] Intensity Modulated Radiation Therapy (IMRT) in Advanced Inoperable Non-small Cell Lung Cancer: Toxicity, Survival, and Patterns of Failure
    Russo, J. K.
    Armeson, K. E.
    Bertke, M.
    Lyons, K.
    Sharma, A. K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S566 - S566
  • [23] Comparison of 3D Conformal Radiotherapy (3DCRT) and Intensity Modulated Radiotherapy (IMRT) in Stage III Non-Small Cell Lung Cancer (NSCLC)
    McCloskey, P. M.
    Atallah, S.
    Coate, L.
    Albert-Green, A.
    Hope, A. J.
    Cho, J.
    Brade, A. M.
    Sun, A.
    Shepherd, F. A.
    Bezjak, A.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) : S213 - S213
  • [24] Intensity-modulated radiation therapy with concurrent chemotherapy followed by durvalumab for stage III non-small cell lung cancer: A multi-center retrospective study
    Tsukita, Yoko
    Yamamoto, Takaya
    Mayahara, Hiroshi
    Hata, Akito
    Takeda, Yuichiro
    Nakayama, Hidetsugu
    Tanaka, Satoshi
    Uchida, Junji
    Usui, Kazuhiro
    Toyoda, Tatsuya
    Tamiya, Motohiro
    Morimoto, Masahiro
    Oya, Yuko
    Kodaira, Takeshi
    Miyauchi, Eisaku
    Jingu, Keiichi
    Sugiura, Hisatoshi
    RADIOTHERAPY AND ONCOLOGY, 2021, 160 : 266 - 272
  • [25] Survival and Toxicity of Hypofractionated Intensity Modulated Radiation Therapy in 4 Gy Fractions for Unresectable Stage III Non-Small Cell Lung Cancer
    Kong, Cheng
    Zhu, Xiangzhi
    Shi, Meiqi
    Wang, Li
    Chen, Cheng
    Tao, Hua
    Jiang, Ning
    Yan, Pengwei
    Zhao, Lijun
    Song, Xue
    He, Xia
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 107 (04): : 710 - 719
  • [26] Retrospective Analysis of Omitting Clinical Target Volume for Stage III Non-Small Cell Lung Cancer Treated With Intensity Modulated Radiation Therapy
    Zhu, G.
    Liang, X.
    Yu, R.
    Shi, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E415 - E415
  • [27] Postoperative adjuvant chemotherapy and radiotherapy for stage II and III non-small cell lung cancer (NSCLC)
    Lee, SW
    Choi, EK
    Chung, WK
    Shin, KH
    Ahn, SD
    Kim, JH
    Kim, SW
    Suh, C
    Lee, JS
    Kim, WS
    Kim, DS
    Kim, DK
    Park, SI
    Sohn, KH
    LUNG CANCER, 2002, 37 (01) : 65 - 71
  • [28] Toxicity and Local Control With Intensity Modulated Radiation Therapy (IMRT) Using a Simultaneous Integrated Boost (SIB) Hypofractionated Approach for Non-Small Cell Lung Cancer (NSCLC)
    Swanick, C. W.
    Naik, N. S.
    Liao, Z.
    Allen, P. K.
    Welsh, J.
    Komaki, R.
    Chang, J. Y.
    O'Reilly, M. S.
    Lin, S. H.
    Gomez, D. R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S508 - S508
  • [29] Intensity-modulated radiation therapy in non-small cell lung cancers
    Ayadi, M.
    Zahra, N.
    Thariat, J.
    Bouilhol, G.
    Boissard, P.
    Van Houtte, P.
    Claude, L.
    Mornex, F.
    CANCER RADIOTHERAPIE, 2014, 18 (5-6): : 406 - 413
  • [30] Survival Outcomes with Photodynamic Therapy, Chemotherapy and Radiation in Patients with Stage III or Stage IV Non-Small Cell Lung Cancer
    Chhatre, Sumedha
    Vachani, Anil
    Allison, Ron R.
    Jayadevappa, Ravishankar
    CANCERS, 2021, 13 (04) : 1 - 11